BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. 1990

C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Department of Parasitology, School of Public Health, University of North Carolina, Chapel Hill 27599.

The antiprotozoal compound 1,5-di(4-amidinophenoxy)pentane (pentamidine) and 36 of its analogs were screened for in vitro activity against Leishmania mexicana amazonensis clone 669 C4S (MHOM/BR/73/M2269) and Plasmodium falciparum clones W2 (Indochina III/CDC) and D6 (Sierra Leone I/CDC). Pentamidine and each of the analogs tested exhibited activity in vitro against L. m. amazonensis and P. falciparum. The pentamidine analogs were more effective against the P. falciparum clones than against L. m. amazonensis. P. falciparum was extremely susceptible to these compounds, with 50% inhibitory concentrations as low as 0.03 microM. While none of the analogs exhibited marked improvement in antileishmanial activity compared with pentamidine, 12 of the pentamidine analogs showed activity approximately equal to or greater than that of the parent compound. From the promising activity exhibited by the pentamidine analogs in this in vitro study and their potential for reduced toxicity relative to the parent drug, pentamidine-related compounds hold promise as new agents for the treatment of protozoal infections.

UI MeSH Term Description Entries
D007894 Leishmania mexicana A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector. Leishmania (Leishmania) mexicana,Leishmania mexicana amazonensis,Leishmania mexicana mexicana,Leishmania leishmania mexicana,Leishmania leishmania mexicanas,Leishmania mexicana amazonenses,Leishmania mexicana mexicanas,Leishmania mexicanas,amazonenses, Leishmania mexicana,amazonensis, Leishmania mexicana,leishmania mexicana, Leishmania,mexicana amazonensis, Leishmania,mexicana mexicana, Leishmania,mexicana mexicanas, Leishmania,mexicana, Leishmania,mexicana, Leishmania leishmania,mexicana, Leishmania mexicana,mexicanas, Leishmania leishmania
D010419 Pentamidine Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. Pentamidine Isethionate,Diamidine,Lomidine,NebuPent,Pentacarinat,Pentam,Pentamidin,Pentamidine Mesylate
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015767 Mefloquine A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects. Lariam,Mefloquine Hydrochloride,Mephloquine,Ro-21-5998-001,WR-142,490,WR-177,602,Ro 21 5998 001,Ro215998001,WR 142,490,WR 177,602,WR142,490,WR177,602

Related Publications

C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Pharmacophore model for pentamidine analogs active against Plasmodium falciparum.
December 2010, European journal of medicinal chemistry,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis.
December 1985, Annals of tropical medicine and parasitology,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Activity of ketoconazole derivatives against Leishmania mexicana amazonensis within mouse peritoneal macrophages.
April 1990, Annals of tropical medicine and parasitology,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis.
May 1981, Lancet (London, England),
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Interactions between Plasmodium yoelii and Leishmania mexicana amazonensis in Leishmania resistant C57B1/6 mice.
December 1988, The American journal of tropical medicine and hygiene,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Effect of pentamidine isethionate on the ultrastructure and morphology of Leishmania mexicana amazonensis in vitro.
February 1982, Annals of tropical medicine and parasitology,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Heme binding to Leishmania mexicana amazonensis.
May 1988, Molecular and biochemical parasitology,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes.
January 1987, Clinical and experimental immunology,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine.
September 2008, Experimental parasitology,
C A Bell, and J E Hall, and D E Kyle, and M Grogl, and K A Ohemeng, and M A Allen, and R R Tidwell
Inhibition of growth of Leishmania mexicana mexicana by Leishmania mexicana amazonensis during "in vitro" co-cultivation.
January 1987, Memorias do Instituto Oswaldo Cruz,
Copied contents to your clipboard!